Presented at the American Urological Association's 2025 Annual Meeting, this new data builds on Avenda Health's previous study demonstrating Unfold AI's ability to predict extracapsular extension risk ...

Prostate cancer is the second leading cause of cancer-related deaths among American men, claiming almost 35,000 lives annually. Androgens, male sex hormones, fuel the growth of most prostate tumors by ...

An artificial intelligence–digital pathology algorithm to predict outcomes in a cohort of men diagnosed with prostate cancer within a low resource setting. This is an ASCO Meeting Abstract from the ...

Targeted cancer therapies are an expanding field of effective therapeutic approaches. While previous chemotherapy agents indiscriminately killed rapidly proliferating cells, newer “precision medicine” ...

Low-Dose Versus Standard-Dose Abiraterone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Multicenter Randomized Phase III Trial The Systemic Therapy in Advancing or Metastatic ...